Cancer

US Healthcare Tech Firm Launches AI-Powered Early Detection Application that Transforms Wearable Devices into Life-Saving Tool Providing Peace of Mind

KANSAS CITY, Kan., Nov. 5, 2025 /PRNewswire/ -- Guardian Alpha announces its product release. Combining AI technology with wearable integration,...

NanoViricides Annual Shareholders Meeting to be Held at 10 am on Saturday, November 5th at on Saturday, November 8, 2025, at the Hampton Inn & Suites Stamford, CT

Normunity announces first patient dosed in Phase 1 clinical study of NRM-823, a T Cell Engager against a novel tumor-specific target, in patients with solid tumors

Phase 1a/1b study will evaluate NRM-823 as monotherapy and in combination with immune checkpoint inhibition in patients with locally-advanced or...

Healthcare Analytics Market Size to grow USD 532.75 Billion by 2035, at 25.75% CAGR | Vantage Market Research

NEW YORK, Nov. 4, 2025 /PRNewswire/ -- The Global Healthcare Analytics Market is poised for exponential expansion, rising from USD 42.96 billion...

Global AI-Powered Pathology Market Valued at USD 184 Million in 2023, Set to Grow at 11.7% CAGR Through 2030 | Valuates Reports

BANGALORE, India, Nov. 4, 2025 /PRNewswire/ -- What is the Market Size of AI-Powered Pathology Market? The global AI-Powered Pathology...

AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients

Clinical trial data demonstrates how Bio-Techne's spatial biology technology and Nucleai's AI-powered multimodal platforms can identify predictive biomarkers in immunotherapy...

RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th

MOUNTAIN VIEW, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life-sciences company...

error: Content is protected !!